Benchmark: Global Benchmark for Efficient Drug Pricing (GLOBE) Model: Proposed Medicare Part B Payment Reform

Take this benchmark to assess how much you would benefit from taking the course on the Global Benchmark for Efficient Drug Pricing (GLOBE) Model Proposed Rule.

This short pre-course benchmark helps you gauge your grasp of why the GLOBE Model exists, who it affects, and what trade-offs it tests. It’s not a recall quiz; it surfaces whether you understand the policy intent, operational impacts, and practical readiness considerations.

What you’ll get from taking this benchmark:

• Clarity on how international price benchmarks could change Medicare Part B drug payments and beneficiary coinsurance.
• Insight into who bears costs and who sees relief first (manufacturers, providers, beneficiaries), and why.
• A feel for core trade-offs (savings vs. access, compliance vs. flexibility, price discipline vs. innovation signals).
• Awareness of operational shifts you may need to plan for, like coinsurance recalculations and payment splits.
• A personalized sense of whether the full course will help you make better decisions, craft comments, or prepare your organization.

Who should take it:

• Anyone who touches Medicare Part B drugs—policy, finance, clinical operations, market access, or advocacy.
• Teams preparing for potential changes to rebates, pricing strategy, or beneficiary out-of-pocket costs.

How it works:

• 10 brief, plain-spoken questions—no dates or definitions—focused on implications and trade-offs.
• Your results highlight topics to focus on in the course so you can get the most value in less time.

If the benchmark surfaces gaps or uncertainty, the course will walk you through the GLOBE Model’s purpose, structure, and real-world impacts—so you can act with confidence.